|
ARL6IP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.078400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.512220E-01 |
| Normal-vs-Stage2 |
3.870600E-01 |
| Normal-vs-Stage3 |
9.502000E-02 |
| Normal-vs-Stage4 |
2.918600E-01 |
| Stage1-vs-Stage2 |
4.860100E-02 |
| Stage1-vs-Stage3 |
1.596330E-02 |
| Stage1-vs-Stage4 |
1.458600E-01 |
| Stage2-vs-Stage3 |
5.088800E-01 |
| Stage2-vs-Stage4 |
5.723800E-01 |
| Stage3-vs-Stage4 |
9.691000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.500800E-01 |
| Normal-vs-AfricanAmerican |
4.229400E-01 |
| Normal-vs-Asian |
9.431400E-01 |
| Caucasian-vs-AfricanAmerican |
2.649600E-01 |
| Caucasian-vs-Asian |
9.157800E-01 |
| AfricanAmerican-vs-Asian |
7.429800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.094200E-01 |
| Normal-vs-Female |
2.583400E-01 |
| Male-vs-Female |
7.258100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.642400E-01 |
| Normal-vs-Extreme_Weight |
4.077800E-01 |
| Normal-vs-Obese |
7.640600E-01 |
| Normal-vs-Extreme_Obese |
4.672800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.152400E-01 |
| Normal_Weight-vs-Obese |
5.783000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.855400E-01 |
| Extreme_Weight-vs-Obese |
2.558400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.515400E-01 |
| Obese-vs-Extreme_Obese |
3.268400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.232600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.373600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.762800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.576000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.791000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.221000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.944200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.391900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.488800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.260600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.698400E-01 |
| Normal-VS-Type2 PRCC |
8.201400E-01 |
| Normal-VS-KIRP CIMP |
2.523800E-02 |
| Normal-VS-Unclassified PRCC |
5.755400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.878800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.810200E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
3.811400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.296390E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
5.157000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.867570E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.036000E-01 |
| Normal-vs-N1 |
9.811600E-02 |
| Normal-vs-N2 |
3.555200E-01 |
| N0-vs-N1 |
3.422200E-02 |
| N0-vs-N2 |
2.944000E-01 |
| N1-vs-N2 |
5.474400E-01 |
|
|
